Micro Labs Limited — Lisinopril Exporter Profile
Indian Pharmaceutical Exporter · #4 for Lisinopril · $1.9M export value · DGFT Verified
Micro Labs Limited is the #4 Indian exporter of Lisinopril with $1.9M in export value and 50 verified shipments. Micro Labs Limited holds a 3.2% market share in Lisinopril exports across 5 countries. The company exports 76 pharmaceutical products worth $463.6M across 21 therapeutic categories.
Micro Labs Limited — Lisinopril Export Profile: Buyers & Destinations
Where Does Micro Labs Limited Export Lisinopril?
| Country | Value | Shipments | Share |
|---|---|---|---|
| TURKEY | $671.0K | 16 | 43.5% |
| UNITED KINGDOM | $628.4K | 19 | 40.7% |
| RUSSIA | $154.1K | 8 | 10.0% |
| VIETNAM | $50.0K | 1 | 3.2% |
| VIETNAM, DEMOCRATIC REP. OF | $21.1K | 1 | 1.4% |
| TRINIDAD & TOBAGO | $19.2K | 5 | 1.2% |
Micro Labs Limited exports Lisinopril to 6 countries. The largest destination is TURKEY accounting for 43.5% of Micro Labs Limited's Lisinopril shipments, followed by UNITED KINGDOM (40.7%) and RUSSIA (10.0%). These destinations reflect Micro Labs Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Lisinopril from Micro Labs Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| BROWN AND BURK UK LIMITED | UNITED KINGDOM | $628.4K | 19 |
| HAWKARY PHARMACEUTICAL COMPANY# | TURKEY | $537.4K | 13 |
| HAWKARY PHARMACEUTICAL COMPANY | TURKEY | $133.7K | 3 |
| OOO "LIFE CELL" LTD | RUSSIA | $93.5K | 6 |
| OOO LIFE CELL LTD | RUSSIA | $60.6K | 2 |
| DA NANG PHARMACEUTICAL MEDICAL | VIETNAM | $50.0K | 1 |
| DA NANG PHARMACEUTICAL | VIETNAM, DEMOCRATIC REP. OF | $21.1K | 1 |
| TRINPHARM CO LTD | TRINIDAD & TOBAGO | $19.2K | 5 |
Micro Labs Limited supplies Lisinopril to 8 buyers globally. The largest buyer is BROWN AND BURK UK LIMITED (UNITED KINGDOM), followed by HAWKARY PHARMACEUTICAL COMPANY# (TURKEY) and HAWKARY PHARMACEUTICAL COMPANY (TURKEY). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Lisinopril Export Value and How Much Does Micro Labs Limited Contribute?
India exported $15.9M worth of Lisinopril through 3,514 shipments from 221 suppliers to 94 countries, serving 450 buyers globally. Micro Labs Limited contributes $1.9M to this total, accounting for 3.2% of India's Lisinopril exports. Micro Labs Limited ships Lisinopril to 6 countries through 8 buyers.
What Is the Average Shipment Value for Micro Labs Limited's Lisinopril Exports?
Micro Labs Limited's average Lisinopril shipment value is $38.7K per consignment, based on 50 shipments totaling $1.9M. The largest destination is TURKEY (43.5% of Micro Labs Limited's Lisinopril exports).
How Does Micro Labs Limited Compare to Other Indian Lisinopril Exporters?
Micro Labs Limited ranks #4 among 221 Indian Lisinopril exporters with a 3.2% market share. The top 3 exporters are LUPIN LIMITED ($4.3M), IPCA LABORATORIES LIMITED ($2.7M), MICRO LABS LIMITED ($1.9M). Micro Labs Limited processed 50 shipments to 5 destination countries.
What Lisinopril Formulations Does Micro Labs Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| HIPRIL - A (AMLODIPINE 5MG & LISINOPRIL5MG TABLETS) (3X10S) - TAX INVOICE NO: 712202959 DT; 23.04.2024 | $135.6K | 3 |
| HIPRIL - A (AMLODIPINE 5MG + LISINOPRIL5MG TABLETS) (3X10S) - TAX INVOICE NO: 712203004 DT; 23.05.2024 | $132.5K | 3 |
| LISINOPRIL TABLETS 20MG (2X14sX209200) - | $100.0K | 2 |
| HIPRIL - A (AMLODIPINE LISINOPRIL TABLET | $100.0K | 2 |
| LISINOPRIL TABLETS 10MG (2X14s) - TAX INVOICE NO: 701209760 DT: 31.01.2025 | $100.0K | 2 |
| HIPRIL - A (AMLODIPINE & LISINOPRIL TABLETS) (3X10S) - TAX INVOICE NO: 712202849DT: 19.02.2024PCS | $69.2K | 3 |
| EQUACARD(5+5) (AMLODIPINE 5MG + LISINOPRIL 5MG TABLETS USP) (3X10SX44970)NOS | $64.3K | 3 |
| LISINOPRIL TABLETS 20MG IH 2X14sX208880 TAX INVOICE NO 701207144 DT 20 03 2023 | $50.0K | 1 |
| HIPRIL A AMLODIPINE AND LISINOPRIL TABLETS 3X10s TAX INVOICE NO 712202418 DT 25 03 2023 | $50.0K | 1 |
| LISINOPRIL TABLETS 10MG (2X14sX208360) - | $50.0K | 1 |
Micro Labs Limited exports 34 distinct Lisinopril formulations including tablets, capsules, syrups, and combination drugs. The top formulation is HIPRIL - A (AMLODIPINE 5MG & LISINOPRIL5MG TABLETS) (3X10S) with 3 shipments worth $135.6K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.
Regulatory Requirements: Exporting Lisinopril to Key Markets
What Micro Labs Limited must comply with to export Lisinopril to its top destination countries
United Kingdom — MHRA
Approval Process
Post-Brexit UK Marketing Authorisation via national procedure. Separate from EU approval since January 2021.
Timeline: 12–15 months
GMP & Export Requirements
UK GMP compliance; MHRA inspection of manufacturing site
Manufacturer Import Authorisation (MIA) held by UK importer; Qualified Person (QP) batch release
Note: Post-Brexit: EU GMP certificates no longer automatically valid in UK. Separate MHRA recognition required.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Micro Labs Limited Compare to Nearest Lisinopril Exporters?
Exporters ranked immediately above and below #4 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 2 | LUPIN LIMITED | $4.3M | 86 | 2 | $50.0K |
| 3 | IPCA LABORATORIES LIMITED | $2.7M | 418 | 10 | $6.4K |
| 4 | MICRO LABS LIMITED ★ | $1.9M | 50 | 5 | $38.7K |
| 7 | AUROBINDO PHARMA LTD | $1.7M | 183 | 9 | $9.6K |
| 8 | MARKSANS PHARMA LIMITED | $936.1K | 47 | 1 | $19.9K |
Micro Labs Limited ranks #4 among 221 Indian Lisinopril exporters. Average shipment value of $38.7K compared to the market average of $72.1K. The closest competitors by value are LUPIN LIMITED and IPCA LABORATORIES LIMITED.
Which Indian Ports Ship Lisinopril Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 597 | 17.0% |
| DELHI AIR CARGO ACC (INDEL4) | 514 | 14.6% |
| SAHAR AIR | 509 | 14.5% |
| DELHI AIR | 282 | 8.0% |
| NHAVA SHEVA SEA (INNSA1) | 238 | 6.8% |
| Bombay Air | 172 | 4.9% |
| HYDERABAD ICD (INSNF6) | 112 | 3.2% |
| Delhi Air | 110 | 3.1% |
Geopolitical & Trade Policy Impact on Micro Labs Limited's Lisinopril Exports
The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Micro Labs Limited. The Israel-Iran conflict has intensified tensions in the Red Sea, leading to increased shipping costs and potential delays. These disruptions can affect supply chain efficiency and profitability, necessitating strategic adjustments in logistics and distribution channels.
Conversely, the U.S.-China trade tensions have prompted the United States to diversify its pharmaceutical supply sources, creating an opportunity for Indian exporters to capture a larger market share. Micro Labs can leverage this shift by emphasizing its compliance with U.S. regulatory standards and ensuring a reliable supply chain.
The recent India-European Union Free Trade Agreement, signed in January 2026, is poised to eliminate tariffs on most European pharmaceutical exports to India. While this enhances market access for European manufacturers, it also intensifies competition for Indian exporters. Micro Labs must enhance its value proposition through innovation, cost efficiency, and adherence to EU regulatory standards to maintain its competitive edge. (en.wikipedia.org)
Micro Labs Limited — Regulatory Compliance & Quality Standards
Compliance with international regulatory standards is paramount for pharmaceutical exporters. Micro Labs Limited has demonstrated a commitment to quality, as evidenced by its recognition as India’s Most Technically and Scientifically Advanced Pharmaceutical Manufacturing Company in 2024. This accolade reflects the company's adherence to stringent manufacturing practices and international guidelines. (einnews.com)
However, the evolving regulatory landscape, including the EU's Falsified Medicines Directive and the U.S. FDA's stringent quality requirements, necessitates continuous investment in compliance infrastructure. Micro Labs must proactively adapt to these changes to ensure uninterrupted market access and maintain its reputation for quality.
About Micro Labs Limited
Micro Labs Limited exports 76 products worth $463.6M. Beyond Lisinopril, top products include Amoxicillin, Potassium, Gabapentin, Losartan, Esomeprazole. View the complete Micro Labs Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Lisinopril — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Lisinopril shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Micro Labs Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 50 individual customs records matching Micro Labs Limited exporting Lisinopril, covering 34 formulations to 6 countries via 8 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 94+ countries, 450+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Lisinopril Export Data from Micro Labs Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Micro Labs Limited's Lisinopril exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Micro Labs Limited
Full Company Profile →
76 products · $463.6M total trade · 21 categories
Lisinopril Stats
Company Overview
Top Products by Micro Labs Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Micro Labs Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Lisinopril. For current shipment-level data, contact TransData Nexus.